Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Investing Activities: 2019-2024

Historic Cash from Investing Activities for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to $139.9 million.

  • Agilon Health's Cash from Investing Activities fell 5992.96% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year decrease of 7438.92%. This contributed to the annual value of $139.9 million for FY2024, which is 41779.69% up from last year.
  • Per Agilon Health's latest filing, its Cash from Investing Activities stood at $139.9 million for FY2024, which was up 41779.69% from -$44.0 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Cash from Investing Activities registered a high of $139.9 million during FY2024, and its lowest value of -$444.4 million during FY2022.
  • Its 5-year average for Cash from Investing Activities is -$83.4 million, with a median of -$44.0 million in 2023.
  • Per our database at Business Quant, Agilon Health's Cash from Investing Activities skyrocketed by 53608.7% in 2020 and then tumbled by 51016.04% in 2021.
  • Over the past 5 years, Agilon Health's Cash from Investing Activities (Annual) stood at $22.1 million in 2020, then plummeted by 510.16% to -$90.5 million in 2021, then tumbled by 391.0% to -$444.4 million in 2022, then surged by 90.09% to -$44.0 million in 2023, then surged by 417.8% to $139.9 million in 2024.
  • Its Cash from Investing Activities was $139.9 million in FY2024, compared to -$44.0 million in FY2023 and -$444.4 million in FY2022.